Merrimack Pharmaceuticals, Inc. MACK
Trading inactive
MACK
Merrimack Pharmaceuticals, Inc. SLRN
Acelyrin, Inc. CRGX
CARGO Therapeutics, Inc. Common Stock SPPI
Spectrum Pharmaceuticals, Inc. THRD
Third Harmonic Bio, Inc. TCRT
Alaunos Therapeutics, Inc. INXB
Inhibrx Biosciences, Inc. CBLI
Cytocom, Inc. ZVRA
Zevra Therapeutics, Inc. CATB
Catabasis Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc. SLRN
Acelyrin, Inc. CRGX
CARGO Therapeutics, Inc. Common Stock SPPI
Spectrum Pharmaceuticals, Inc. THRD
Third Harmonic Bio, Inc. TCRT
Alaunos Therapeutics, Inc. INXB
Inhibrx Biosciences, Inc. CBLI
Cytocom, Inc. ZVRA
Zevra Therapeutics, Inc. CATB
Catabasis Pharmaceuticals, Inc.
Performance
| Periode | MACK | SLRN | CRGX | SPPI | THRD | TCRT | INXB | CBLI | ZVRA | CATB |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 14.39 % | -27.94 % | 17.63 % | 31.75 % | 53.71 % | 13.01 % | 13.94 % | 0.00 % | 49.52 % | 0.00 % |
| YTD | 13.79 % | -31.21 % | -70.30 % | 167.97 % | -51.27 % | 36.53 % | 13.94 % | 0.00 % | 23.40 % | 0.00 % |
| 1Y | 21.55 % | -42.96 % | -81.53 % | -10.87 % | -60.15 % | 29.93 % | 13.94 % | 252.18 % | 30.87 % | 0.00 % |
| 3Y | 136.64 % | -87.39 % | -69.24 % | -75.65 % | -68.35 % | -98.44 % | -90.67 % | 56.93 % | 93.04 % | 0.00 % |
| 5Y | 240.34 % | -87.39 % | -69.24 % | -95.47 % | -68.35 % | -99.18 % | -90.67 % | -2.46 % | 12.42 % | 0.00 % |
| 10Y | -74.80 % | -87.39 % | -69.24 % | -86.62 % | -68.35 % | -99.85 % | 1 486.00 % | -90.73 % | -95.79 % | 0.00 % |
| From the beginning | -68.13 % | -87.39 % | -69.24 % | -99.25 % | -68.35 % | -99.89 % | 1 486.00 % | -97.01 % | -93.97 % | 0.00 % |